HCP
CVS icon

Hexagon Capital Partners’s CVS Health CVS Stock Holding History

Hexagon Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$587K Sell
5,672
-934
-14% -$83.4K 0.08% 112
2026
Q1 		$474K Buy
+6,606
New +$509K 0.07% 122
2025
Q2 		– Sell
-7,353
Closed -$498K – 454
2025
Q1 		$498K Buy
7,353
+674
+10% +$40.3K 0.09% 103
2024
Q4 		$300K Buy
6,679
+1,411
+27% +$79.2K 0.05% 151
2024
Q3 		$331K Buy
5,268
+178
+3% +$10.4K 0.06% 136
2024
Q2 		$301K Buy
5,090
+157
+3% +$9.82K 0.07% 146
2024
Q1 		$393K Sell
4,933
-179
-4% -$13.7K 0.09% 118
2023
Q4 		$404K Buy
5,112
+716
+16% +$51K 0.1% 110
2023
Q3 		$307K Buy
4,396
+1,499
+52% +$106K 0.08% 120
2023
Q2 		$200K Buy
2,897
+522
+22% +$37.1K 0.05% 161
2023
Q1 		$176K Buy
2,375
+281
+13% +$23.6K 0.05% 170
2022
Q4 		$195K Sell
2,094
-1,188
-36% -$115K 0.06% 154
2022
Q3 		$313K Sell
3,282
-1,486
-31% -$147K 0.09% 111
2022
Q2 		$442K Sell
4,768
-452
-9% -$44.1K 0.13% 90
2022
Q1 		$528K Sell
5,220
-212
-4% -$22.3K 0.14% 89
2021
Q4 		$560K Buy
5,432
+686
+14% +$63.4K 0.15% 83
2021
Q3 		$403K Sell
4,746
-48
-1% -$4.02K 0.12% 92
2021
Q2 		$400K Buy
4,794
+1,053
+28% +$86.2K 0.11% 98
2021
Q1 		$281K Sell
3,741
-693
-16% -$50.5K 0.08% 114
2020
Q4 		$302K Buy
4,434
+130
+3% +$8.46K 0.09% 95
2020
Q3 		$249K Buy
+4,304
New +$268K 0.08% 99

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Hexagon Capital Partners's CVS Position: Q2 2026 in Review

Hexagon Capital Partners reduced its CVS Health (CVS) stake by 14% in Q2 2026, selling an estimated $83.4K and leaving 5,672 shares worth $587K. The position accounts for 0.08% of the portfolio, ranked #112.

Hexagon Capital Partners first reported a position in CVS in Q3 2020 and has held it in 21 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Hexagon Capital Partners held 5,672 shares of CVS Health worth $587K as of Q2 2026.
  • Hexagon Capital Partners sold 934 CVS Health shares in Q2 2026, an estimated $83.4K.
  • CVS Health made up 0.08% of Hexagon Capital Partners's portfolio in Q2 2026, its #112 holding.
  • Hexagon Capital Partners first reported a position in CVS Health in Q3 2020 and has held it in 21 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Hexagon Capital Partners's 13F filing for Q2 2026, filed 7 Aug 2026.